journal article·2026-03Open access

Wireless Bioelectronic Modulation of Membrane Potential in Glioblastoma Using Carbon Nanotube Porins

Fleur Groualle, David Onion, Julie A. Watts, Graham A. Rance, Aleksandr Noy, Beth Coyle, Frankie J. Rawson

Advanced Science· Volume 13· Issue 16

Abstract

ABSTRACT Disruption of membrane potential (V mem ) can activate pathways associated with cancer proliferation. Manipulating ion channels may therefore present an effective strategy for treating cancers that fail to respond to conventional therapies. One approach to target these channels is to manipulate the membrane charge, which involves the use of wireless bipolar electrodes such as carbon nanotube porins (CNTPs) inserted into cell membranes to modulate membrane charge and ionic flux. By utilizing membrane dyes, we observed alterations in V mem induced by CNTPs and externally applied voltages. Analyses of cellular behaviors and processes indicated that V mem is more receptive to stimuli in invasive cancers, while it leads to increased metabolism in less invasive cancers, with notable changes in the cell cycle occurring at approximately 48 h post‐treatment in Glioblastoma (GB) cell lines. This work shows that CNTPs, in combination and with externally applied voltages, can modulate V mem and alter cancer cell processes, supporting their potential as a therapeutic.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanopore and Nanochannel Transport Studies · Ion channel regulation and function · Microbial Inactivation Methods

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Bioelectronics Laboratory, Division of Regenerative Medicine and Cellular Therapies, School of Pharmacy University of Nottingham Nottingham UK

Flow Cytometry Facility, Medical School, School of Life Sciences University of Nottingham Nottingham UK

Nanoscale and Microscale Research Centre (nmRC), Cripps South Building University of Nottingham Nottingham UK

Materials Science Division Lawrence Livermore National Laboratory Livermore USA

School of Natural Sciences University of California Merced Merced California USA

Children's Brain Tumour Research Centre, Translational Medical Sciences, School of Medicine, Biodiscovery Institute University of Nottingham Nottingham UK

Funding

Engineering and Physical Sciences Research Council

References (61)

Show source-provided references
1. 10.1021/acsanm.9b0137410.1021/acsanm.9b01374 ↗
2. 10.1002/adtp.20200024810.1002/adtp.202000248 ↗
3. 10.1002/wnan.169310.1002/wnan.1693 ↗
4. 10.1186/S42234‐018‐0001‐Z10.1186/S42234‐018‐0001‐Z ↗
5. 10.4172/2324‐9110.s1‐00210.4172/2324‐9110.s1‐002 ↗
6. 10.3389/fphys.2015.0014310.3389/fphys.2015.00143 ↗
7. 10.1089/bioe.2019.001310.1089/bioe.2019.0013 ↗
8. 10.3390/cancers702081310.3390/cancers7020813 ↗
9. 10.3389/fcell.2022.77223010.3389/fcell.2022.772230 ↗
10. 10.1091/mbc.E13‐12‐070810.1091/mbc.E13‐12‐0708 ↗
11. 10.1007/s12015‐009‐9080‐210.1007/s12015‐009‐9080‐2 ↗
12. 10.3390/cancers1103028710.3390/cancers11030287 ↗
13. 10.1016/j.ceca.2021.10236810.1016/j.ceca.2021.102368 ↗
14. 10.7554/eLife.8164510.7554/eLife.81645 ↗
15. 10.1155/2017/915737010.1155/2017/9157370 ↗
16. 10.3389/fimmu.2022.97648210.3389/fimmu.2022.976482 ↗
17. 10.1007/s13193‐022‐01533‐710.1007/s13193‐022‐01533‐7 ↗
18. 10.3390/ijms1811245210.3390/ijms18112452 ↗
19. 10.1093/noajnl/vdaa08710.1093/noajnl/vdaa087 ↗
20. 10.1152/jn.1998.79.5.278210.1152/jn.1998.79.5.2782 ↗
21. 10.3390/ijms2403253010.3390/ijms24032530 ↗
22. 10.1186/1476‐4598‐10‐1710.1186/1476‐4598‐10‐17 ↗
23. 10.1007/0‐387‐68919‐2_310.1007/0‐387‐68919‐2_3 ↗
24. 10.1146/annurev.bi.64.070195.00242510.1146/annurev.bi.64.070195.002425 ↗
25. 10.1016/S0896‐6273(00)80981‐210.1016/S0896‐6273(00)80981‐2 ↗
26. 10.3389/fphys.2013.0018510.3389/fphys.2013.00185 ↗
27. 10.1098/rstb.2013.010810.1098/rstb.2013.0108 ↗
28. 10.1098/rstb.2013.010410.1098/rstb.2013.0104 ↗
29. 10.3390/cancers1304066810.3390/cancers13040668 ↗
30. 10.1016/j.bbabio.2019.06.01210.1016/j.bbabio.2019.06.012 ↗
31. 10.3390/cancers1210306810.3390/cancers12103068 ↗
32. 10.1038/s41565‐023‐01496‐y10.1038/s41565‐023‐01496‐y ↗
33. 10.1002/smll.20150251010.1002/smll.201502510 ↗
34. 10.1038/s41467‐020‐17288‐010.1038/s41467‐020‐17288‐0 ↗
35. 10.3390/ijms2006143710.3390/ijms20061437 ↗
36. 10.1016/j.trechm.2024.10.00510.1016/j.trechm.2024.10.005 ↗
37. 10.1126/science.aan243810.1126/science.aan2438 ↗
38. 10.1021/jp906038k10.1021/jp906038k ↗
39. 10.1021/nl072652s10.1021/nl072652s ↗
40. 10.1021/acsomega.1c0354710.1021/acsomega.1c03547 ↗
41. 10.1073/pnas.201697411810.1073/pnas.2016974118 ↗
42. 10.1038/s41598‐020‐68059‐210.1038/s41598‐020‐68059‐2 ↗
43. 10.1002/smll.20210251710.1002/smll.202102517 ↗
44. 10.1016/j.bbcan.2010.02.00410.1016/j.bbcan.2010.02.004 ↗
45. 10.1186/s42234‐019‐0018‐y10.1186/s42234‐019‐0018‐y ↗
46. 10.1038/nprot.2016.11910.1038/nprot.2016.119 ↗
47. 10.1021/MA902433V10.1021/MA902433V ↗
48. 10.1039/D1NA00293G10.1039/D1NA00293G ↗
49. 10.1016/S0022‐2836(65)80093‐610.1016/S0022‐2836(65)80093‐6 ↗
50. 10.1242/JCS.114.14.269710.1242/JCS.114.14.2697 ↗
51. 10.1101/2024.03.16.58516210.1101/2024.03.16.585162 ↗
52. 10.1007/s00232‐013‐9584‐110.1007/s00232‐013‐9584‐1 ↗
53. 10.1016/J.INS.2024.12140510.1016/J.INS.2024.121405 ↗
54. 10.1016/B978‐0‐12‐821736‐8.00012‐110.1016/B978‐0‐12‐821736‐8.00012‐1 ↗
55. 10.1016/B978‐0‐323‐95975‐9.00017‐210.1016/B978‐0‐323‐95975‐9.00017‐2 ↗
56. 10.4161/cc.8.21.988810.4161/cc.8.21.9888 ↗
57. 10.2174/18755607MTExxNjQhy10.2174/18755607MTExxNjQhy ↗
58. 10.15252/embj.201910176710.15252/embj.2019101767 ↗
59. 10.3390/PHARMACEUTICS1302020810.3390/PHARMACEUTICS13020208 ↗
60. 10.5402/2011/59024910.5402/2011/590249 ↗
61. 10.1016/j.devcel.2020.10.01110.1016/j.devcel.2020.10.011 ↗